Follow
Silvio Danese
Silvio Danese
Verified email at hsr.it - Homepage
Title
Cited by
Cited by
Year
Vedolizumab as induction and maintenance therapy for ulcerative colitis
BG Feagan, P Rutgeerts, BE Sands, S Hanauer, JF Colombel, ...
New England Journal of Medicine 369 (8), 699-710, 2013
26342013
Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target
L Peyrin-Biroulet, W Sandborn, BE Sands, W Reinisch, W Bemelman, ...
Official journal of the American College of Gastroenterology| ACG 110 (9 …, 2015
18292015
The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management
A Dignass, G Van Assche, JO Lindsay, M Lémann, J Söderholm, ...
Journal of Crohn's and Colitis 4 (1), 28-62, 2010
17662010
Tofacitinib as induction and maintenance therapy for ulcerative colitis
WJ Sandborn, C Su, BE Sands, GR D’Haens, S Vermeire, S Schreiber, ...
New England Journal of Medicine 376 (18), 1723-1736, 2017
16942017
STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD …
D Turner, A Ricciuto, A Lewis, F D’amico, J Dhaliwal, AM Griffiths, ...
Gastroenterology 160 (5), 1570-1583, 2021
13772021
Epithelial NEMO links innate immunity to chronic intestinal inflammation
A Nenci, C Becker, A Wullaert, R Gareus, G Van Loo, S Danese, M Huth, ...
Nature 446 (7135), 557-561, 2007
12192007
Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis
R Panaccione, S Ghosh, S Middleton, JR Márquez, BB Scott, L Flint, ...
Gastroenterology 146 (2), 392-400. e3, 2014
10502014
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial
J Panés, D García-Olmo, G Van Assche, JF Colombel, W Reinisch, ...
The Lancet 388 (10051), 1281-1290, 2016
10102016
Ustekinumab as induction and maintenance therapy for ulcerative colitis
BE Sands, WJ Sandborn, R Panaccione, CD O’Brien, H Zhang, J Johanns, ...
New England Journal of Medicine 381 (13), 1201-1214, 2019
9652019
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial
JF Colombel, R Panaccione, P Bossuyt, M Lukas, F Baert, T Vaňásek, ...
The Lancet 390 (10114), 2779-2789, 2017
8382017
The safety of vedolizumab for ulcerative colitis and Crohn's disease
JF Colombel, BE Sands, P Rutgeerts, W Sandborn, S Danese, G D'Haens, ...
Gut 66 (5), 839-851, 2017
8332017
3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 2: surgical management and special situations
P Gionchetti, A Dignass, S Danese, FJ Magro Dias, G Rogler, PL Lakatos, ...
Journal of Crohn's and Colitis 11 (2), 135-149, 2017
7902017
Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease
RM Gadaleta, KJ Van Erpecum, B Oldenburg, ECL Willemsen, W Renooij, ...
Gut 60 (4), 463-472, 2011
7542011
Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines
J Panes, Y Bouhnik, W Reinisch, J Stoker, SA Taylor, DC Baumgart, ...
Journal of Crohn's and Colitis 7 (7), 556-585, 2013
7372013
Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention, and management
F D’amico, DC Baumgart, S Danese, L Peyrin-Biroulet
Clinical Gastroenterology and hepatology 18 (8), 1663-1672, 2020
7302020
Development of the Crohn's disease digestive damage score, the Lemann score
B Pariente, J Cosnes, S Danese, WJ Sandborn, M Lewin, JG Fletcher, ...
Inflammatory bowel diseases 17 (6), 1415-1422, 2011
7112011
Crohn’s disease
G Roda, S Chien Ng, PG Kotze, M Argollo, R Panaccione, A Spinelli, ...
Nature Reviews Disease Primers 6 (1), 22, 2020
7012020
Tolerogenic dendritic cells: cytokine modulation comes of age
S Rutella, S Danese, G Leone
Blood 108 (5), 1435-1440, 2006
6602006
Vedolizumab versus adalimumab for moderate-to-severe ulcerative colitis
BE Sands, L Peyrin-Biroulet, EV Loftus Jr, S Danese, JF Colombel, ...
New England Journal of Medicine 381 (13), 1215-1226, 2019
6332019
European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases
AU Dignass, C Gasche, D Bettenworth, G Birgegård, S Danese, ...
Journal of Crohn's and Colitis 9 (3), 211-222, 2015
6262015
The system can't perform the operation now. Try again later.
Articles 1–20